查詢結果分析
來源資料
頁籤選單縮合
題 名 | 市售中藥補養劑四種重金屬含量之調查 |
---|---|
作 者 | 鄧瑞惠; 王東亮; 林維炤; 陳銘田; 陳榮秀; | 書刊名 | 藥物食品分析 |
卷 期 | 3:3 1995.09[民84.09] |
頁 次 | 頁193-202 |
分類號 | 414.33 |
關鍵詞 | 中藥補養劑; 重金屬含量; Atomic absorption spectrophotometry; Chinese medicine; Heavy metal content; |
語 文 | 中文(Chinese) |
英文摘要 | This study undertook the analysis of Cd, Cr, Mn, and Pb constituents in the various forms of five restorative preparations from ten GMP Chinese medicine laboratories. Collected samples of the commercial drugs were digested with HN03- HCl04 in the presence of microwaving, followed by atomic absorption spectrophotometric analysis. The results showed higher levels in the Mn content (27.9±19.8 ppm) than Cr (2.86±2.04 ppm), Pb (0.247±0. 578 ppm), and Cd (0.157±0.167 ppm), based on the dry weight of the samples. The variation of heavy metal contents between laboratories, prescriptions, prescribed doses, and lot numbers may be attributed to the differences in the origin of raw materials as well as the additives used in the processing procedure. Comparison between prescriptions exhibited higher heavy metal contents (53.6±24.7 ppm, the sum of Cd, Cr, Mn and Pb) in Kim-So-Ku-Gien-Wan. For purposes of safety and quality in Chinese drugs, it is necessary to confine individual heavy metal content on the basis of potential toxicity. |
本系統中英文摘要資訊取自各篇刊載內容。